A Proof of Concept Study Concerning Efficacy of SN132D in Patients With Suspected Endometriosis
Status:
Recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
This is a Phase IIa, open-label, non-randomised and non-placebo-controlled study. The study
is designed to evaluate the diagnostic value and safety of a single intravenous dose of
SN132D in up to 18 participants with suspected endometriosis. Magnetic resonance imaging
(MRI) will be performed pre- and post-infusion of SN132D.